Novonesis AS

Transaction in Own Shares • Aug 24, 2012

August 24, 2012

On January 20, 2012, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 1,000 million in the period from January 20, 2012, to December 31, 2012.

The following transactions have been made under the program:

	Number of shares	Average purchase price	Transaction value, DKK
Accumulated, last announcement	3,987,307		627,340,516
August 17, 2012	25,000	157.91	3,947,802
August 20, 2012	25,000	158.83	3,970,707
August 21, 2012	25,000	161.96	4,049,120
August 22, 2012	25,000	163.15	4,078,794
August 23, 2012	15,000	164.78	2,471,743
Accumulated under the program	4,102,307		645,858,682

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 42,530 B shares in the period from August 17, to August 23, 2012. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 11,893,659 treasury shares, corresponding to 3.7% of the share capital. The total amount of shares in the company is 325,000,000 including treasury shares.

Contact persons:

Press and media: Investor relations: René Tronborg (Europe) Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274

Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501 Maarit Pokkinen Tlf. (direkte): +45 4446 8682 Tlf. (mobil): +45 3077 8682 Martin Riise Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27